114 related articles for article (PubMed ID: 9067336)
1. Nitric oxide differentially affects constitutive cytochrome P450 isoforms in rat liver.
Khatsenko O; Kikkawa Y
J Pharmacol Exp Ther; 1997 Mar; 280(3):1463-70. PubMed ID: 9067336
[TBL] [Abstract][Full Text] [Related]
2. Differential inductive and suppressive effects of endotoxin and particulate irritants on hepatic and renal cytochrome P-450 expression.
Sewer MB; Koop DR; Morgan ET
J Pharmacol Exp Ther; 1997 Mar; 280(3):1445-54. PubMed ID: 9067334
[TBL] [Abstract][Full Text] [Related]
3. Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450.
Sewer MB; Koop DR; Morgan ET
Drug Metab Dispos; 1996 Apr; 24(4):401-7. PubMed ID: 8801054
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of the expression of three major rat liver cytochrome P450S by endotoxin in vivo occurs independently of nitric oxide production.
Sewer MB; Morgan ET
J Pharmacol Exp Ther; 1998 Oct; 287(1):352-8. PubMed ID: 9765356
[TBL] [Abstract][Full Text] [Related]
5. Suppression of rat hepatic cytochrome P450s by protein-calorie malnutrition: complete or partial restoration by cysteine or methionine supplementation.
Cho MK; Kim YG; Lee MG; Kim SG
Arch Biochem Biophys; 1999 Dec; 372(1):150-8. PubMed ID: 10562428
[TBL] [Abstract][Full Text] [Related]
6. Fluconazole-induced hepatic cytochrome P450 gene expression and enzymatic activities in rats and mice.
Sun G; Thai SF; Lambert GR; Wolf DC; Tully DB; Goetz AK; George MH; Grindstaff RD; Dix DJ; Nesnow S
Toxicol Lett; 2006 Jun; 164(1):44-53. PubMed ID: 16406388
[TBL] [Abstract][Full Text] [Related]
7. Enzyme-selective effects of nitric oxide on affinity and maximum velocity of various rat cytochromes P450.
Vuppugalla R; Mehvar R
Drug Metab Dispos; 2005 Jun; 33(6):829-36. PubMed ID: 15778270
[TBL] [Abstract][Full Text] [Related]
8. Hepatic disposition and effects of nitric oxide donors: rapid and concentration-dependent reduction in the cytochrome P450-mediated drug metabolism in isolated perfused rat livers.
Vuppugalla R; Mehvar R
J Pharmacol Exp Ther; 2004 Aug; 310(2):718-27. PubMed ID: 15051803
[TBL] [Abstract][Full Text] [Related]
9. The regulation of cytochrome P450 2E1 during LPS-induced inflammation in the rat.
Abdulla D; Goralski KB; Renton KW
Toxicol Appl Pharmacol; 2006 Oct; 216(1):1-10. PubMed ID: 16712892
[TBL] [Abstract][Full Text] [Related]
10. Role of nitric oxide in the cytokine-mediated regulation of cytochrome P-450.
Carlson TJ; Billings RE
Mol Pharmacol; 1996 May; 49(5):796-801. PubMed ID: 8622628
[TBL] [Abstract][Full Text] [Related]
11. Short-term inhibitory effects of nitric oxide on cytochrome P450-mediated drug metabolism: time dependency and reversibility profiles in isolated perfused rat livers.
Vuppugalla R; Mehvar R
Drug Metab Dispos; 2004 Dec; 32(12):1446-54. PubMed ID: 15383494
[TBL] [Abstract][Full Text] [Related]
12. Suppression of hepatic drug metabolism by the interferon inducer, polyriboinosinic acid:polyribocitidylic acid.
Sakai H; Okamoto T; Kikkawa Y
J Pharmacol Exp Ther; 1992 Oct; 263(1):381-6. PubMed ID: 1403800
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of hepatic cytochrome p450 in chronic renal failure: role of uremic mediators.
Guévin C; Michaud J; Naud J; Leblond FA; Pichette V
Br J Pharmacol; 2002 Dec; 137(7):1039-46. PubMed ID: 12429576
[TBL] [Abstract][Full Text] [Related]
14. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
15. Expression and inducibility of cytochrome P450 isoforms in 1-year-old intrasplenic liver cell transplants in rats.
Lupp A; Danz M; Müller D; Klinger W
Transpl Int; 2002 Mar; 15(2-3):96-107. PubMed ID: 11935166
[TBL] [Abstract][Full Text] [Related]
16. Hepatic and central nervous system cytochrome P450 are down-regulated during lipopolysaccharide-evoked localized inflammation in brain.
Renton KW; Nicholson TE
J Pharmacol Exp Ther; 2000 Aug; 294(2):524-30. PubMed ID: 10900228
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide-mediated inhibition of cytochrome P450 by interferon-gamma in human hepatocytes.
Donato MT; Guillén MI; Jover R; Castell JV; Gómez-Lechón MJ
J Pharmacol Exp Ther; 1997 Apr; 281(1):484-90. PubMed ID: 9103535
[TBL] [Abstract][Full Text] [Related]
18. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
[TBL] [Abstract][Full Text] [Related]
19. Rapid transcriptional suppression of rat cytochrome P450 genes by endotoxin treatment and its inhibition by curcumin.
Cheng PY; Wang M; Morgan ET
J Pharmacol Exp Ther; 2003 Dec; 307(3):1205-12. PubMed ID: 14557382
[TBL] [Abstract][Full Text] [Related]
20. Regulation of hepatic cytochrome P450 2C11 by transforming growth factor-beta, hepatocyte growth factor, and interleukin-11.
Iber H; Morgan ET
Drug Metab Dispos; 1998 Oct; 26(10):1042-4. PubMed ID: 9763412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
